Supplementary Table 1 from A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors

openalex（2023）

引用 0|浏览2

暂无评分

摘要

Supplementary Table 1 - PDF file 54K, Number (percentage) of patients exhibiting increased ventricular ectopic activity

查看译文

关键词

antitumor activity,inhibitor,quisinostat,solid tumors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要